Relationship Graph Explorer

Follow the connections

Every herb, ingredient, formula, gene target, and disease — connected through real research. Search, pick a subject, and navigate the graph in any direction.

🌿

Herb

→

→

→

→

🧪

Evidence

23,295

trials · metas · refs

Plus 6,743 TCM formulas connecting herbs together

Subject Type: 🌿 Herbs ⚗️ Ingredients 📜 Formulas 🧬 Targets 🏥 Diseases

Quick picks: Abetalipoproteinemia Abortion, Habitual Agenesis Acanthamoeba Keratitis Acanthosis Nigricans Achondrogenesis Achondroplasia Acne Vulgaris Acne Keloid Apert Syndrome

🏥 Disease / Health Topic

Bladder cancer

Clinical Trials

Meta-Analyses

PubMed References

📋 Sample Trials

NCT00118040

Phase II Study of Isoflavone G-2535 (Genistein) in Patients With Bladder Cancer

Completed · Phase 2

NCT01489813

Study of Genistein in Reducing Side Effects of Superficial Bladder Cancer Treatment

Active_Not_Recruiting · Phase 2

NCT04046094

Intravenous (IV) Vitamin C With Chemotherapy for Cisplatin Ineligible Bladder Cancer Patients

Active_Not_Recruiting · Phase 1|Phase 2

📊 Sample Meta-Analyses

CRD42016053826

A protocol for systematic review and meta-analysis of the estimated odds ratios for the opium effect on bladder cancer

Bladder cancer is responsible for more than 7% of neoplasms especially among men

CRD42018112605

A systematic review of community-based drinking water interventions to mitigate arsenic exposure in lower-income countries

The review focuses on community-based interventions that aim to reduce participa

CRD42019141632

Urinary arsenic level and diabetes: a dose-response meta-analysis

Chronic arsenic exposure is associated with a variety of adverse health outcomes

📚 Sample References

None linked yet.

🏥 All Disease / Health Topic data fields for Bladder cancer

🏥 Names

Disease Name

Bladder cancer

Topic Type

disease

🔍 Raw view — every non-empty column on this row (14 fields)

name

Bladder cancer

topic type

disease

tcmsp disease id

103

🌿 Related Herbs

1 · contains this compound

Ephedra

Ma Huang

⚗️ Related Ingredients

18 · compounds in this herb

🧬 Gene / Protein Targets

3 · genes implicated in this disease

PPARG

Gene PPARG

Prostaglandin G/H synthase 2

Cellular tumor antigen p53

📋 Clinical Trials

12 · subject of clinical study

NCT00118040 Phase II Study of Isoflavone G-2535 (Genistein) in Patients With Bladder Cancer

→ Recurrent Bladder Carcinoma|Stage I Bladder Cancer

NCT01489813 Study of Genistein in Reducing Side Effects of Superficial Bladder Cancer Treatm

→ Bladder Cancer

NCT04046094 Intravenous (IV) Vitamin C With Chemotherapy for Cisplatin Ineligible Bladder Ca

→ Bladder Cancer

NCT00033436 Radiation Therapy With or Without Carbogen and Niacinamide in Treating Patients

→ Bladder Cancer

NCT00365508 Counseling and Nicotine Replacement Therapy in Helping Adult Smokers Quit Smokin

→ Bladder Cancer|Cervical Cancer|Esophageal Cancer|G

NCT00790569 Varenicline or Nicotine Patch and Nicotine Gum in Helping Smokers in a Methadone

→ Bladder Cancer|Cervical Cancer|Esophageal Cancer|G

NCT00002917 Paclitaxel in Treating Patients With Early-Stage Bladder Cancer

→ Bladder Cancer

NCT00002949 Vinorelbine and Paclitaxel Plus Radiation Therapy in Treating Patients With Adva

→ Bladder Cancer|Cervical Cancer|Endometrial Cancer|

NCT00022191 Cisplatin Plus Gemcitabine With or Without Paclitaxel in Treating Patients With

→ Bladder Cancer|Transitional Cell Cancer of the Ren

NCT00055835 S0121, Neoadjuvant Carboplatin, Paclitaxel, and Gemcitabine Followed by Cisplati

→ Bladder Cancer|Urethral Cancer

NCT00136175 Paclitaxel, Carboplatin and Gemcitabine in the Treatment of Patients With Advanc

→ Bladder Cancer

NCT00238420 Paclitaxel and Radiation Therapy With or Without Trastuzumab in Treating Patient

→ Bladder Urothelial Carcinoma|Stage I Bladder Cance

📊 Meta-Analyses

11 · systematic review

CRD42016053826 A protocol for systematic review and meta-analysis of the estimated odds ratios

→ Bladder cancer is responsible for more than 7% of

CRD42018112605 A systematic review of community-based drinking water interventions to mitigate

→ The review focuses on community-based intervention

CRD42019141632 Urinary arsenic level and diabetes: a dose-response meta-analysis

→ Chronic arsenic exposure is associated with a vari

CRD42022381522 Arsenic in drinking water and urinary tract cancers: a systematic review update

→ Urinary bladder cancer and kidney cancer

CRD42019123716 Comparison between fluoropyrimidine-cisplatin and gemcitabine-cisplatin as first

→ Advanced biliary tract cancer (cholangiocarcinoma

CRD42020196422 Comparision of oncologic outcomes associated with neoadjuvant chemotherapy Dose

→ Muscle invasive bladder cancer

CRD42021289342 Therapeutic effects and mechanisms of action of epigallocatechin gallate on blad

→ Bladder cancer is a common urinary cancer worldwid

CRD42021289342 Therapeutic effects and mechanisms of action of epigallocatechin gallate on blad

→ Bladder cancer is a common urinary cancer worldwid

CRD42014013093 Vitamin D and prostate cancer: a systematic review of the literature

→ Cancer (prostate and bladder cancer), Nutrition (h

CRD42019140284 Correlations between ApaI, BsmI, FokI, and TaqI polymorphisms in the vitamin D r

→ Bladder cancer (BCa) is the ninth most common freq

CRD42023448504 Meta-analysis of the clinical efficacy and safety of Compound Kushen Injection c

→ To systematically evaluate the efficacy and safety

How relationships are computed

Clinical Trials / Meta-Analyses / References: direct foreign-key link via subject_entity_id (Phase 2d wireup)
Formula ↔ Herbs: text bridge via formulas.herbs_in_pinyin matching herbs.pinyin_name
Herb ↔ Ingredient: ACTIVE — direct link via herb_ingredients
Ingredient ↔ Target: ACTIVE — direct link via ingredient_targets
Target ↔ Disease: ACTIVE — direct link via target_health_topics
Herb → Target → Disease (full chemical spine): ACTIVE — joins all three link tables